tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market

Lexicon Pharmaceuticals (LXRX) Income Statement

Compare
1,537 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q4 2024), Lexicon Pharmaceuticals's total revenue was $26.55M, an increase of 3682.62% from the same quarter last year. In Q4, Lexicon Pharmaceuticals's net income was $-33.77M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 31.08M$ 1.20M$ 139.00K$ 298.00K$ 24.00M
Gross Profit
$ 30.46M$ 1.12M$ -288.00K$ -54.75M$ 22.07M
Operating Expenses
$ 227.58M$ 172.87M$ 100.90M$ 87.39M$ 200.85M
Depreciation and Amortization
$ 534.00K$ 554.00K$ 427.00K$ 292.00K$ 2.93M
EBITDA
$ -184.29M$ -163.46M$ -98.74M$ -86.66M$ -41.10M
Operating Income
$ -197.12M$ -171.75M$ -100.76M$ -87.09M$ -178.78M
Other Income/Expenses
$ -3.29M$ -5.37M$ -1.18M$ -668.00K$ -10.77M
Pretax Income
$ -200.40M$ -177.12M$ -101.94M$ -87.76M$ -58.57M
Net Income
$ -200.40M$ -177.12M$ -103.13M$ -88.27M$ -70.18M
Per Share Metrics
Basic EPS
$ -0.63$ -0.80$ -0.62$ -0.61$ -0.63
Diluted EPS
$ -0.63$ -0.80$ -0.62$ -0.61$ -0.63
Weighted Average Shares Outstanding
320.03M 221.13M 165.73M 145.65M 110.84M
Weighted Average Shares Outstanding (Diluted)
320.03M 221.13M 165.73M 145.65M 110.84M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis